Recruiting A Multicenter, Prospective Clinical Trial With a Concurrent Control Evaluating Methotrexate Combined With Rituximab,Sintilimab and Pirtobrutinib vs. Investigator-Selected Standard of Care in Treatment-Naive PCNSL NCT07350850 Conditions PCNSL, Primary Central Nervous System Lymphoma Locations The First Affiliated Hospital of Fujian Medical University — Xiamen, Fujian, China Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology — Wuhan, Hubei, China China-Japan Union Hospital of Jilin University — Changchun, Jilin, China Shanxi Provincial People's Hospital — Taiyuan, Shanxi, China View Trial Details
Recruiting A Study of Pomadomide in Combination With Rituximab and Methotrexate for Newly-diagnosed Primary Central Nervous System Lymphoma NCT06554561 Conditions PCNSL Locations 2nd Affiliated Hospital, School of Medicine, Zhejiang University — Hanzhou, Zhejiang, China View Trial Details
Not Yet Recruiting Neurocognitive Assessment CNSL and LGG NCT07710131 Conditions Brain Diseases, Brain Neoplasms, Brain Tumor, +13 more Locations Not specified View Trial Details
Completed A Nomogram for Predicting the Diagnosis of Central Malignant Tumors Based on Preoperative Clinical Characteristics and Laboratory Indicators: NCT06914700 Conditions Central Malignant Tumors, GBM, Glioma, +8 more Locations Not specified View Trial Details
Active, Not Recruiting Real World Data on Ibrutinib Use in PCNSL Rel/Ref NCT05782374 Conditions PCNSL Locations Ospedale San Raffaele — Milan, Italy View Trial Details
